This 2-hour self-paced course from the African American Behavioral Health Center of Excellence is for mental health and substance use disorder practitioners and primary care physicians who seek to provide culturally responsive care. Its focus is on helping the workforce understand the presence and impact of implicit racial bias in health care and mental health treatment.
This online video course provides a foundational understanding of Medications for Opioid Use Disorder (MOUD), exploring their benefits and applications in treating opioid addiction. Participants will learn about specific medications such as Buprenorphine, Methadone, and Naltrexone, along with strategies to engage clients in treatment discussions and empower informed decision-making. Presented by Krista Hales, DBH LADC-S, this training is ideal for professionals seeking to enhance their knowledge and skills in opioid addiction treatment.
The CDC page outlines the importance of medication-assisted treatment (MAT) for opioid use disorder (OUD) during pregnancy, emphasizing methadone and buprenorphine as effective options to improve maternal and neonatal outcomes. It also highlights the need for comprehensive care, including mental health support, to reduce relapse risks and manage withdrawal symptoms in newborns.
This guide reviews ways that telehealth modalities can be used to provide treatment for serious mental illness and substance use disorders among adults, distills the research into recommendations for practice, and provides examples of how these recommendations can be implemented.
This SAMHSA manual offers best practices to states, tribes, and local communities on collaborative treatment approaches for pregnant women living with opioid use disorders, and the risks and benefits associated with medication-assisted treatment.